Skip to content
DataLookout
Menu

NCT06501924

Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss

StatusWithdrawn
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Withdrawn before enrolling Sponsor's reason: Sponsor change of formulation Show 5 more changesShow less
    • Primary completion pushed from Oct 17, 2025 to Oct 17, 2027
    • Enrollment target: estimated 516 to confirmed 0
    • Start date: Jan 15, 2025 to Jan 15, 2027
    • Eligibility criteria expanded, about 13 words
    • Study completion pushed from Dec 12, 2025 to Dec 12, 2027
  2. Minor Study description expanded, about 6 wordsv10
  3. Notable Start date: Nov 15, 2024 to Jan 15, 2025v9
  4. Notable Eligibility criteria revised
    • Study description revised
    v8
  5. Minor Interventions: DA-001 (Dietary Supplement), DA-002 (Drug), Placebo Oral Tablet (Dietary Supplement), Placebo Topical Solution (Other), Topical minoxidil… to DA-002 (Drug), DA-005 (Dietary Supplement), Placebo Oral Tablet (Dietary Supplement), Placebo Topical Solution (Other), Topical minoxidil…
    • Study title revised
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Start date: Sep 16, 2024 to Nov 15, 2024v6 Show 6 more changesShow less
    • Primary completion date: Jul 11, 2025 to Oct 17, 2025
    • Study completion date: Sep 12, 2025 to Dec 12, 2025
    • Interventions: Daniel Alain Botanical Supplement Treatment for Hair Loss (Dietary Supplement), Topical minoxidil 5% (Drug) to DA-001 (Dietary Supplement), DA-002 (Drug), Placebo Oral Tablet (Dietary Supplement), Placebo Topical Solution (Other), Topical minoxidil…
    • Study description expanded, about 40 words
    • Study arms: 2 to 3
    • Study title expanded, about 3 words
  2. Notable Primary endpoints: 1 to 2v5
  3. Minor Primary completion date: Jul 15, 2025 to Jul 11, 2025
    • Study completion date: Sep 15, 2025 to Sep 12, 2025
    • Start date: Sep 15, 2024 to Sep 16, 2024
    v4
  4. Minor Primary completion date: Mar 15, 2025 to Jul 15, 2025
    • Study completion date: Jun 15, 2025 to Sep 15, 2025
    v3
  5. Minor Collaborators: 1 to 2v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Target Area Hair Counts
Timeframe: Week [0,12]

Arms and interventions

DA-005Experimental

Oral Botanical Supplement HIF-1a inhibitor

Topical Minoxidil 5%Active comparator

Topical Minoxidil 5%

DA-002Experimental

Topical Alpha 1 Agonist

Dietary supplements: DA-005, Placebo Oral Tablet

Drugs: Topical minoxidil 5%, DA-002

Other: Placebo Topical Solution